The Claim

In adults aged 60–65 without cardiovascular disease but at intermediate risk, daily combination therapy with rosuvastatin (10 mg), candesartan (16 mg), and hydrochlorothiazide (12.5 mg) for a median of 5.6 years reduces the incidence of stroke by 44% compared to dual placebo, with an absolute risk reduction of 0.8 percentage points.

Source: Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
82score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

Among adults aged 60 to 65 without cardiovascular disease but at intermediate risk, taking a daily pill containing rosuvastatin, candesartan, and hydrochlorothiazide for about 5.6 years lowers the rate of stroke by 44% compared to taking two placebo pills, resulting in 0.8 fewer strokes per 100 people.

See the scientific wording

In adults aged 60–65 without cardiovascular disease but at intermediate risk, daily combination therapy with rosuvastatin (10 mg), candesartan (16 mg), and hydrochlorothiazide (12.5 mg) for a median of 5.6 years reduces the incidence of stroke by 44% compared to dual placebo, with an absolute risk reduction of 0.8 percentage points.

Why this might work

Lowering bad cholesterol prevents fatty buildup in brain arteries, while lowering blood pressure reduces force on artery walls; together, this stops plaques from rupturing and forming clots that block blood flow to the brain.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

    Taking a daily pill with three medicines for about six years helped middle-aged and older adults at moderate risk avoid heart attacks, strokes, or heart-related deaths — about 1 in 72 people benefited. The study confirms this combo works, though the exact stroke reduction number in the claim is a bit off.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.